Pilot Evaluation of Hospice Decision Support Tools

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-15

Study Completion Date

2020-03-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this project is to determine the feasibility and acceptability of a hospice decision aid among a diverse population of older adults at multiple stages of illness (Aim 1) and to determine the preliminary efficacy of the hospice decision aid on decision quality, hospice knowledge, and values-concordance (Aim 2). By testing the feasibility, acceptability, and preliminary efficacy of a novel hospice Patient Decision Aid (PTDa) in a diverse population of older adults, additionally the study will simultaneously explore barriers to PtDA implementation in both an outpatient primary care and inpatient palliative care setting. The study will also gather sufficient pilot data to support a subsequent effectiveness/implementation trial and thus address the absence of quality of SDM interventions for end-of-life care decision-making.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults

NCT03960476

Alzheimer Disease Mild Cognitive Impairment

ACTIVE_NOT_RECRUITING NA

Feasibility Of An Advanced Care Decision Aid Among Patients And Physicians_Matlock

NCT01190488

Palliative Care Decision Making Decision Support Techniques +2 more

COMPLETED NA

Home Based Care Transitions Tailored by Cognition and Patient Activation

NCT02045147

Chronic Disease

COMPLETED NA

Effectiveness of a Comprehensive Patient-centered Hospital Discharge Planning Intervention for Frail Older Adults

NCT04154917

Frail Older Adults

ACTIVE_NOT_RECRUITING NA

Involving Nursing Home Residents and Their Families in Acute Care Transfer Decisions

NCT02568475

Chronic Disease Acute Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospice End-of-life Decision Making Hospice Decision Making

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Participants will receive hospice decisional support materials and be asked to review them. Participants will provide feedback on tools and complete feasibility, efficacy and knowledge assessments.

Group Type OTHER

Hospice Decision Aids

Intervention Type OTHER

Paper and video hospice decision aid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hospice Decision Aids

Paper and video hospice decision aid

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 65 or older.
* At least one life-limiting illness or syndrome.

Exclusion Criteria

* Non-English speakers.
* Patients with cognitive Impairments preventing ability to provide informed consent.
* Patients on isolation precautions due to resistant bacteria or impaired immune function.

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No